![Jeffrey Poulton](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 19 M $ al 30/06/2026
El Sr. Jeffrey V. Poulton es director independiente de Homology Medicines, Inc. y director financiero y contable de Alnylam Pharmaceuticals, Inc. Es miembro del Consejo de Administración de Homology Medicines, Inc., Alnylam UK Ltd. y EIP Pharma, Inc. Anteriormente, el Sr. Poulton fue director financiero de Indigo Agriculture, Inc. y director financiero y ejecutivo de Shire Plc. Se licenció en la Universidad de Duke y obtuvo un MBA en la Escuela de Negocios Kelley.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 04/03/2026 | 61.862 ( 0,05 % ) | 19 M $ | 30/06/2026 | |
CERVOMED INC. 0,12 % | 08/06/2026 | 16.444 ( 0,12 % ) | 50 976 $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. | Director Financiero/CFO | 13/08/2019 |
| CERVOMED INC. | Director/Miembro de la Junta | 16/08/2023 |
EIP Pharma, Inc.
 EIP Pharma, Inc. BiotechnologyHealth Technology Operates as a clinical-stage company focused on developing treatments for neurodegenerative diseases | Director/Miembro de la Junta | - |
Alnylam UK Ltd.
 Alnylam UK Ltd. BiotechnologyHealth Technology Develops biotechnology products | Director/Miembro de la Junta | 13/08/2019 |
| Empresas | Cargo | Fin |
|---|---|---|
Indigo Ag, Inc.
 Indigo Ag, Inc. Chemicals: AgriculturalProcess Industries Develops biological microbial seed treatments | Director Financiero/CFO | 01/04/2019 |
| SHIRE | Director Financiero/CFO | 01/01/2015 |
| Q32 BIO INC. | Director/Miembro de la Junta | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 9 |
|---|---|
Shire Plc
 Shire Plc Pharmaceuticals: MajorHealth Technology Develops and markets medicines for patients with rare diseases | Health Technology |
Duke University
 Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alnylam Pharmaceuticals, Inc.
 Alnylam Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics based on RNA interference | Health Technology |
Kelley School of Business
 Kelley School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Indigo Ag, Inc.
Indigo Ag, Inc. Chemicals: AgriculturalProcess Industries Develops biological microbial seed treatments | Process Industries |
EIP Pharma, Inc.
EIP Pharma, Inc. BiotechnologyHealth Technology Operates as a clinical-stage company focused on developing treatments for neurodegenerative diseases | Health Technology |
Homology Medicines, Inc.
 Homology Medicines, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage genetic medicines company | Health Technology |
Alnylam UK Ltd.
Alnylam UK Ltd. BiotechnologyHealth Technology Develops biotechnology products | Health Technology |
CervoMed, Inc.
 CervoMed, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biopharmaceutical company that develops novel therapies | Commercial Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
